Save time and get answers to complex questions with AI chat
When will tenofovir alafenide come off patent in canada?Symbravo ingredients mechanism of action?When genetic tenofovir alafenamide be available in us?Guselkumab loss of exclusitivy?Campath litigation germany?
See the DrugPatentWatch profile for doxylamine
Doxylamine is a first‑generation antihistamine, meaning it blocks the histamine H1 receptors that mediate allergy and itching symptoms. Because it also crosses the blood‑brain barrier, it has a strong sedating effect, which makes it useful for a few common purposes: | Purpose | How it works | Typical dose | Notes | |---------|--------------|--------------|-------| | Sleep aid (short‑term) | Blocks H1 receptors in the brain → reduces wakefulness and promotes drowsiness | 25 mg oral, usually taken 30 min before bedtime | Only for occasional use; long‑term insomnia should be managed differently. | | Allergy relief | Antagonizes histamine receptors in the skin, nose, and throat → decreases itching, hives, runny nose, sneezing | 25–50 mg oral every 4–6 h (max 200 mg/day) | May cause drowsiness, especially at higher doses. | | Motion sickness | Similar antihistaminic action on the vestibular system in the inner ear | 25 mg oral 1 h before travel | Can also be used as an anti‑nausea agent. | | Post‑viral cough | Less clear; some formulations combine it with a cough suppressant | 25 mg every 6 h (max 200 mg/day) | Not first‑line for chronic cough. |
Other Questions About Doxylamine :